A detailed history of Franklin Resources Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Franklin Resources Inc holds 3,384 shares of BNTX stock, worth $382,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,384
Previous 3,384 -0.0%
Holding current value
$382,662
Previous $401,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$78.36 - $124.66 $391,486 - $622,801
-4,996 Reduced 59.62%
3,384 $401,000
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $86,065 - $110,173
-1,071 Reduced 11.33%
8,380 $673,000
Q1 2024

May 13, 2024

SELL
$88.96 - $112.35 $39,231 - $49,546
-441 Reduced 4.46%
9,451 $871,000
Q4 2023

Feb 09, 2024

BUY
$90.91 - $112.75 $561,551 - $696,456
6,177 Added 166.27%
9,892 $1.04 Million
Q3 2023

Nov 13, 2023

SELL
$98.5 - $125.08 $22,458 - $28,518
-228 Reduced 5.78%
3,715 $403,000
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $1,641 - $2,074
16 Added 0.41%
3,943 $425,000
Q1 2023

May 12, 2023

BUY
$122.57 - $153.67 $143,161 - $179,486
1,168 Added 42.33%
3,927 $489,000
Q4 2022

Feb 10, 2023

BUY
$118.43 - $186.05 $79,584 - $125,025
672 Added 32.2%
2,759 $414,000
Q2 2022

Aug 11, 2022

SELL
$123.25 - $186.24 $27,484 - $41,531
-223 Reduced 9.65%
2,087 $311,000
Q1 2022

May 13, 2022

SELL
$126.25 - $231.85 $40 Million - $73.5 Million
-317,207 Reduced 99.28%
2,310 $394,000
Q4 2021

Feb 11, 2022

SELL
$216.64 - $362.52 $18.5 Million - $30.9 Million
-85,178 Reduced 21.05%
319,517 $82.4 Million
Q3 2021

Nov 12, 2021

BUY
$205.93 - $447.23 $30.7 Million - $66.7 Million
149,058 Added 58.31%
404,695 $110 Million
Q2 2021

Aug 13, 2021

BUY
$113.32 - $241.49 $28.6 Million - $61 Million
252,580 Added 8262.35%
255,637 $57.2 Million
Q1 2021

May 13, 2021

BUY
$85.73 - $119.5 $262,076 - $365,311
3,057 New
3,057 $334,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.